Sponsor or institution

Clinical trials and research at Peter MacCallum Cancer Centre, Australia

• 13Clinical trials
• 2Countries

Newest trials

All recruiting trials (13)

• KMA-targeted CAR T-cells for relapsed/refractory kappa-restricted multiple myeloma

  This study tests escalating doses of a patient’s own PMCC-COE-KMA CAR T-cells to see if they are safe and effective for relapsed/refractory kappa-restricted multiple myeloma expressing KMA.

  Recruiting Phase 1 Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria · NCT07541391

• Low-level laser (photobiomodulation) to prevent mouth sores during radiotherapy for oral cancer

  This study will try low-level laser therapy (photobiomodulation), given five times a week during radiotherapy, to reduce mouth sores in adults treated for oral cancer.

  Recruiting Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria · NCT07387978

• Pravastatin for long-term swallowing problems after head and neck radiotherapy

  This study will test whether taking pravastatin daily for 12 months can improve long-term swallowing problems in people who had radiotherapy for head and neck cancer.

  Recruiting Phase 2 Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria · NCT07217938

• Does immunotherapy for melanoma affect reproductive organs in premenopausal women and men?

  This study will see if immune checkpoint inhibitor treatment for melanoma changes sex hormone levels and reproductive organ function in adults receiving these drugs.

  Recruiting Peter MacCallum Cancer Centre, Australia · Sydney, New South Wales and 5 other locations · NCT07138222

• Early versus late stopping of antibiotics for adults with high‑risk blood cancers or after stem‑cell or CAR T therapy who develop fever

  This trial tests if stopping antibiotics early is safe for adults with leukemia or after stem‑cell transplant or CAR T therapy when a fever has settled.

  Recruiting at 2 sites Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria and 1 other locations · NCT07051525

• Treatment of Chronic Lymphocytic Leukaemia with Pirtobrutinib after Zanubrutinib

  This study is testing if the drug pirtobrutinib can help people with chronic lymphocytic leukaemia who didn’t respond to or relapsed after treatment with zanubrutinib.

  Recruiting Phase 2 Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria and 2 other locations · NCT06812715

• Epcoritamab treatment for patients with large B-cell lymphoma after CAR T-cell therapy

  This study is testing if a new treatment called Epcoritamab, either on its own or with two other drugs, can help patients with large B-cell lymphoma who haven't responded well after CAR T-cell therapy.

  Recruiting at 3 sites Phase 2 Peter MacCallum Cancer Centre, Australia · Camperdown, New South Wales and 5 other locations · NCT06414148

• Using a special PET scan to detect invasive fungal infections

  This study is testing a special PET scan with a new tracer to see if it can help find invasive fungal infections in people who have recently been diagnosed.

  Recruiting Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria · NCT06105411

• Exploring metabolic features in melanoma

  This study is testing how melanoma affects the way the body processes sugar by looking at tissue and blood samples from patients to better understand the disease.

  Recruiting Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria · NCT05570227

• Using Lu-PSMA with SABR for treating oligometastatic prostate cancer

  This study is testing whether adding a special targeted therapy called Lu-PSMA to radiation treatment can help people with a few spots of prostate cancer live longer without their cancer getting worse.

  Recruiting at 4 sites Phase 2 Peter MacCallum Cancer Centre, Australia · St Leonards, New South Wales and 3 other locations · NCT05560659

• Evaluating a new treatment for men with advanced prostate cancer

  This study is testing a new treatment for men with advanced prostate cancer to see if it's safe and how well it works after they've tried other therapies.

  Recruiting Phase 1/2 Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria · NCT05521412

• Genomic analysis for patients with inherited bone marrow failure

  This study is testing if advanced genetic testing can help identify the causes of inherited bone marrow failure in patients, so they can get better treatment and support.

  Recruiting Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria · NCT05196789

• Combining a PARP inhibitor with targeted radiation therapy for neuroendocrine tumors

  This study is testing if combining a new cancer drug with targeted radiation therapy can safely help people with advanced pancreatic or midgut neuroendocrine tumors.

  Recruiting Phase 1 Peter MacCallum Cancer Centre, Australia · Melbourne, Victoria · NCT05053854

Quick answers

How many clinical trials run by Peter MacCallum Cancer Centre, Australia are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Australia (13 trials), Israel (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →